Getty Images
Oncologist Professor James Larkin talking about the amazing benefits cancer patients have received because of the research of Nobel Prize-winning scientists James Allison and Tasuku Honjo
Oncologist Professor James Larkin talking about the amazing benefits cancer patients have received because of the research of Nobel Prize-winning scientists James Allison and Tasuku Honjo (BBC News 10pm bulletin 01/10/2018 - ABSA627D)
Getty Images
Human Body’s Defense Against Deadly Bacteria
White blood cells defend the body by leaving the blood stream in order to engulf and destroy deadly anthrax bacteria in a process called phagocytosis.
Bloomberg
Plasma Treatment Results Encouraging: Johns Hopkins' Casadevall
Jul.13 -- Dr. Arturo Casadevall, chair of molecular microbiology and immunology at the Johns Hopkins Bloomberg School of Public Health, discusses the impact of convalescent plasma in the fight against Covid-19 with Bloomberg's Vonnie...
Bloomberg
Dr. Sabra Klein on the Gender Risk Factor of Covid-19
Nov.16 -- Dr. Sabra Klein, Professor of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, explains why gender is an important risk factor for Covid-19 and weighs on our progress toward a...
Bloomberg
Here's What Is Known About the Coronavirus So Far
Feb.26 -- Dr. Stanley Perlman, a professor of microbiology and immunology at the University of Iowa, discusses the efforts to combat the spread of the coronavirus. He speaks with Bloomberg's David Westin on "Balance of Power."
Bloomberg
J&J 1Q Pharmaceutical Sales Help Overcome Pessimistic Forecast
Apr.16 -- Joseph Wolk, chief financial officer at Johnson & Johnson, discusses the company’s first-quarter results. He speaks on "Bloomberg Daybreak: Americas."
Bloomberg
J&J CFO on Earnings, Immunology Portfolio and Pricing Pressure
Jan.22 -- Joseph Wolk, Johnson & Johnson chief financial officer, discusses the company's fourth-quarter results, drug portfolio plans and industry pricing pressure with Bloomberg's David Westin on "Balance of Power."
Bloomberg
J&J Raises Forecast as Profit Beats on Drug Sales
Oct. 18 -- Dominic Caruso, chief financial officer at Johnson & Johnson, discusses third-quarter results as profit topped analysts' estimates and the company raised its full-year earnings forecasts. He speaks with Bloomberg's David...
Bloomberg
AstraZeneca to Buy Alexion in $39 Billion Deal
Dec.14 -- AstraZeneca Plc agreed to buy Alexion Pharmaceuticals Inc. for $39 billion, pushing the U.K. company, which has built a turnaround on its strength in oncology, into new areas such as immunology. Sam Fazeli of Bloomberg...
Bloomberg
We'll Be in a Solid Place Entering 2019, Says Novartis' CEO
Oct.18 -- Vas Narasimhan, chief executive officer at Novartis, discusses his outlook for 4Q earnings, their deal to buy Endocyte, return on investment, pricing in the U.S., disclosing prices in television ads and his cost-cutting...
Curated Video
Are Booster Shots The Best Defense Against COVID-19?
Christian Bryant explores the latest information regarding a COVID-19 booster shot ahead of an FDA advisory committee meeting.